These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12625144)

  • 21. Update on the distribution of Mansonella perstans in the southern part of Cameroon: influence of ecological factors and mass drug administration with ivermectin.
    Wanji S; Tayong DB; Layland LE; Datchoua Poutcheu FR; Ndongmo WP; Kengne-Ouafo JA; Ritter M; Amvongo-Adjia N; Fombad FF; Njeshi CN; Nkwescheu AS; Enyong PA; Hoerauf A
    Parasit Vectors; 2016 May; 9(1):311. PubMed ID: 27245442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mansonelliasis identified by a cervicovaginal smear at the university hospital center of Bobo-Dioulasso (Burkina Faso)].
    Bamba S; Barro-Traoré F; Liance M; Da O; Sanou C; Guiguemdé TR
    Med Sante Trop; 2012; 22(4):444-6. PubMed ID: 23392727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of ivermectin in the treatment of concomitant Mansonella perstans infections in onchocerciasis patients.
    Schulz-Key H; Albrecht W; Heuschkel C; Soboslay PT; Banla M; Görgen H
    Trans R Soc Trop Med Hyg; 1993; 87(2):227-9. PubMed ID: 8337736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Albendazole for the treatment of Mansonella perstans filariasis.
    Lipani F; Caramello P; Biglino A; Sacchi C
    Trans R Soc Trop Med Hyg; 1997; 91(2):221. PubMed ID: 9196776
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of Mansonella perstans in western Uganda and its detection using the QBC-fluorescence method.
    Fischer P; Kilian AH; Bamuhiiga J; Kipp W; Büttner DW
    Appl Parasitol; 1996 Jan; 37(1):32-7. PubMed ID: 8574245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mansonella perstans filariasis: failure of albendazole treatment.
    Van den Enden E; Van Gompel A; Vervoort T; Van der Stuyft P; Van den Ende J
    Ann Soc Belg Med Trop; 1992 Sep; 72(3):215-8. PubMed ID: 1476470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unexpected guest in follicular fluid.
    Goverde AJ; Schats R; van Berlo PJ; Claessen FA
    Hum Reprod; 1996 Mar; 11(3):531-2. PubMed ID: 8671260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of repeated doses of ivermectin against Mansonella perstans.
    Gardon J; Kamgno J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO; Boussinesq M
    Trans R Soc Trop Med Hyg; 2002; 96(3):325-6. PubMed ID: 12174789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vitreoretinal dirofilariasis].
    Frieling E; Fritz E; Schmidt U; Klauss V; Schütte E
    Klin Monbl Augenheilkd; 1990 Apr; 196(4):233-6. PubMed ID: 2348641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications.
    Kyelem D; Sanou S; Boatin B; Medlock J; Coulibaly S; Molyneux DH
    Ann Trop Med Parasitol; 2003 Dec; 97(8):827-38. PubMed ID: 14754495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Silico Identification of Novel Biomarkers and Development of New Rapid Diagnostic Tests for the Filarial Parasites Mansonella perstans and Mansonella ozzardi.
    Poole CB; Sinha A; Ettwiller L; Apone L; McKay K; Panchapakesa V; Lima NF; Ferreira MU; Wanji S; Carlow CKS
    Sci Rep; 2019 Jul; 9(1):10275. PubMed ID: 31311985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ivermectin-related adverse clinical events in patients treated for Mansonella ozzardi infections.
    Krolewiecki AJ; Cajal SP; Villalpando C; Gil JF
    Rev Argent Microbiol; 2011; 43(1):48-50. PubMed ID: 21491068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mansonella perstans filariasis in a HIV patient: finding in bone marrow.
    Molina MA; Cabezas MT; Giménez MJ
    Haematologica; 1999 Sep; 84(9):861. PubMed ID: 10477464
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnostic and therapeutic challenges.
    Schatz H
    Retina; 1997; 17(5):440-3. PubMed ID: 9355194
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin.
    Fischer P; Tukesiga E; Büttner DW
    J Infect Dis; 1999 Oct; 180(4):1403-5. PubMed ID: 10479183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ocular toxocariasis--clinical case report].
    Jeske J; Poborc-Godlewska J; Kamerys J; Malińska A
    Wiad Parazytol; 1997; 43(2):223-6. PubMed ID: 9424943
    [No Abstract]   [Full Text] [Related]  

  • 37. The failure of diethylcarbamazine in the treatment of Mansonella ozzardi infections.
    Bartholomew CF; Nathan MB; Tikasingh ES
    Trans R Soc Trop Med Hyg; 1978; 72(4):423-4. PubMed ID: 360502
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment failure of a single high dose of ivermectin for Mansonella perstans filariasis.
    Van den Enden E; Van Gompel A; Van der Stuyft P; Vervoort T; Van den Ende J
    Trans R Soc Trop Med Hyg; 1993; 87(1):90. PubMed ID: 8465410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loa loa and Mansonella perstans infections in Ijebu north, western Nigeria: a parasitological study.
    Agbolade M; Akinboye DO
    Jpn J Infect Dis; 2001 Jun; 54(3):108-10. PubMed ID: 11544400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Verification of New World Mansonella perstans Parasitemias.
    Tavares da Silva LB; Crainey JL; Ribeiro da Silva TR; Suwa UF; Vicente AC; Fernandes de Medeiros J; Pessoa FA; Luz SL
    Emerg Infect Dis; 2017 Mar; 23(3):545-547. PubMed ID: 28221120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.